A Double-Blind, Vehicle Controlled, Randomized, Phase II Study of SR-T100 Gel on External Genital Warts/Condyloma Acuminate (EGWs)

Trial Profile

A Double-Blind, Vehicle Controlled, Randomized, Phase II Study of SR-T100 Gel on External Genital Warts/Condyloma Acuminate (EGWs)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2017

At a glance

  • Drugs SR T100 (Primary)
  • Indications Condylomata acuminata
  • Focus Therapeutic Use
  • Sponsors G&E Herbal Biotechnology
  • Most Recent Events

    • 27 Nov 2017 Planned End Date changed from 1 Jun 2018 to 1 Apr 2018.
    • 27 Nov 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Jan 2018.
    • 01 Jun 2017 Planned number of patients changed from 130 to 111.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top